Advertisement
Contraception
Advanced searchSave search
Research Article| Volume 22, ISSUE 3, P259-269, September 1980

Download started.

Ok

Ectopic pregnancies associated with low dose progestagen-releasing IUDs

DOI:https://doi.org/10.1016/S0010-7824(80)80005-9
Ectopic pregnancies associated with low dose progestagen-releasing IUDs
Previous ArticlePlasmatic and vascular factors of the hemostatic system in rats receiving an estrogen-progestogen combination
Next ArticleThe norgestrel-T IUD
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Dimethyl-polysiloxane capsules containing pure progestagens were attached to Tatum's T IUDs and tested in 594 fertile women for contraceptive performance. The control group was represented by 71 women who received identical devices containing barium sulphate instead of steroid and 100 women who received a Copper T-200. The progestagens and the doses tested were megestrol acetate (4.8, 19.2, 26 and 32 ug/day); levonorgestrel (2.1, 3.4 and 8.5 ug/day); norethindrone (18 ug/day); R2323 (28.6 and 45 ug/day); and norgestrienone (26 ug/day). Twelve pregnancies were diagnosed during 5201 woman-months of exposure accumulated within the first year of use among users of the steroid-bearing IUDs. Five of these were ectopic gestations. Ten pregnancies, all uterine, were detected during 1701 woman-months of exposure in the control group.
      Intrauterine delivery of progestagens by means of a carrier IUD is effective in decreasing the pregnancy rate but it might affect postovulatory events in a way which increases the rate of tubal implantation. Because of this property, progestagen-releasing IUDs should be limited to doses that assure maximal effectiveness to avoid increasing the risk of ectopic pregnancy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Scommegna A.
        • Pandya G.N.
        • Christ M.
        • Lee A.W.
        • Cohen M.R.
        Intrauterine administration of progesterone by a slow releasing device.
        Fertil. Steril. 1970; 21: 201
        • Pandya G.N.
        • Scommegna A.
        Intrauterine progesterone-releasing devices: A clinical trial.
        Excerp. Med. ICS. 1972; 246: 103
        • Pharriss B.B.
        • Erickson R.
        • Bashaw J.
        • Hoff S.
        • Place V.A.
        • Zaffaroni A.
        Progestasert: An uterine therapeutic system for long-term contraception: I. Philosophy and clinical efficacy.
        Fertil. Steril. 1974; 25: 915
        • Martínez-Manautou J.
        • Aznar R.
        • Maqueo M.
        • Pharriss B.B.
        Uterine therapeutic system for long-term contraception: II.Clinical correlates.
        Fertil. Steril. 1974; 25: 922
        • Brenner P.F.
        • Copper D.L.
        • Mishell D.R.
        Clinical study of a progesterone-releasing intrauterine contraceptive device.
        Amer. J. Obstet. Gynec. 1975; 121: 704
        • Pizarro E.
        • Gómez-Rogers C.
        • Rowe P.J.
        • Lucero S.
        Comparative study of the progesterone T (65 ug daily) and copper 7 IUD.
        Contraception. 1977; 16: 313
        • Martínez-Manautou J.
        • Aznar R.
        • Rosado A.
        • Maqueo M.
        Hefnawi F. Segal S.J. Analysis of Intrauterine Contraception. North-Holland/American Elsevier, New York1975: 173
        • Rowe P.J.
        • Hoetsawang S.
        • Pizarro E.
        • Diethelm P.
        Hefnawi F. Segal S.J. Analysis of Intrauterine Contraception. North-Holland/American Elsevier, Amsterdam1975: 185
        • Ragab M.I.
        • Senna I.A.
        Hefnawi F. Segal S.J. Analysis of Intrauterine Contraception. North-Holland/American Elsevier, Amsterdam1975: 325
        • Rowe P.J.
        Diczfalusy E. Regulation of Human Fertility. Scriptor, Amsterdam1977: 381
        • Horne H.W.
        • Scott J.J.
        • Underwood R.H.
        Microdose intrauterine progestagen associated with intrauterine contraceptive devices.
        Inter. J. Fertil. 1970; 15: 210
        • Stryker J.C.
        • Doyle L.L.
        • Clewe T.H.
        • Lippes J.
        Silastic Lippes Loop with crystalline Provera.
        Excerpte Medica ICS. 1972; 246: 100
        • ElMahgoub S.
        Hefnawi F. Segal S.J. Analysis of Intrauterine Contraception. North-Holland/American Elsevier, Copenhagen1975: 317
        • Nilsson C.G.
        • Johansson E.D.B.
        • Luukkainen T.
        A d-Norgestrel-releasing IUD.
        Contraception. 1976; 13: 503
        • Nilsson C.G.
        • Luukkainen T.
        Improvement of a d-Norgestrel-releasing IUD.
        Contraception. 1977; 15: 295
        • Luukkainen T.
        • Nilsson C.G.
        Sustained intrauterine release of d-norgestrel.
        Contraception. 1978; 18: 451
        • Luukkainen T.
        • Nilsson C.G.
        Talwar G.P. Recent Advances in Reproduction and Regulation of Fertility. Elsevier/North-Holland, Amsterdam1979: 551
        • Clewe T.H.
        • Doyle L.L.
        Retention of progestin-releasing intrauterine devices in rats.
        Anat. Rec. 1968; 160: 464
        • Doyle L.L.
        • Clewe T.H.
        Preliminary studies on the effect of hormone-releasing intrauterine devices.
        Amer. J. Obstet. Gynec. 1968; 101: 564
        • Croxatto H.B.
        • Vera R.
        • Parga M.A.
        Resúmenes, IV Reunión de ALIRH, Ixtapan de la Sal.
        in: 1970: 77
        • Nash H.A.
        • Robertson D.N.
        • Jackanicz T.M.
        Release of contraceptive steroids from sustained release dosage forms and resulting plasma levels.
        Contraception. 1978; 18: 395
        • Tatum H.J.
        • Schmidt F.H.
        Contraceptive and sterilization practices and extrauterine pregnancy: A realistic perspective.
        Fertil. Steril. 1977; 28: 407
        • Croxatto H-D.
        • Díaz S.
        • Rosati S.
        • Croxatto H.B.
        Adnexal complications in women under treatment with progestogen implants.
        Contraception. 1975; 12: 629
        • Vessey M.R.
        • Yeates D.
        • Flavel R.
        Risk of ectopic pregnancy and duration of use of an intrauterine device.
        The Lancet. 1970; II: 501

      Article info

      Publication history

      Accepted: July 28, 1980

      Identification

      DOI: https://doi.org/10.1016/S0010-7824(80)80005-9

      Copyright

      © 1980 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX